Literature DB >> 16421143

Interaction between dopamine beta-hydroxylase and interleukin genes increases Alzheimer's disease risk.

I Mateo, J Infante, E Rodríguez, J Berciano, O Combarros, J Llorca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16421143      PMCID： PMC2077586          DOI： 10.1136/jnnp.2005.075358

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Association of interleukin-1 gene polymorphisms with Alzheimer's disease.

Authors:  J A Nicoll; R E Mrak; D I Graham; J Stewart; G Wilcock; S MacGowan; M M Esiri; L S Murray; D Dewar; S Love; T Moss; W S Griffin
Journal:  Ann Neurol       Date:  2000-03       Impact factor: 10.422

2.  Noradrenergic depletion potentiates beta -amyloid-induced cortical inflammation: implications for Alzheimer's disease.

Authors:  Michael T Heneka; Elena Galea; Vitaliy Gavriluyk; Lucia Dumitrescu-Ozimek; JoAnna Daeschner; M Kerry O'Banion; Guy Weinberg; Thomas Klockgether; Douglas L Feinstein
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

3.  Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis.

Authors:  Scott A Lyness; Chris Zarow; Helena C Chui
Journal:  Neurobiol Aging       Date:  2003 Jan-Feb       Impact factor: 4.673

4.  The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population [corrected].

Authors:  Roberto Pola; Andrea Flex; Eleonora Gaetani; Antonio Dal Lago; Laura Gerardino; Paolo Pola; Roberto Bernabei
Journal:  Neuroreport       Date:  2002-09-16       Impact factor: 1.837

5.  A functional polymorphism regulating dopamine beta-hydroxylase influences against Parkinson's disease.

Authors:  Daniel G Healy; Patrick M Abou-Sleiman; Tetsutaro Ozawa; Andrew J Lees; Kailash Bhatia; Kourosh R Ahmadi; Ullrich Wullner; Jose Berciano; J Carsten Moller; Christoph Kamm; Katrin Burk; Paolo Barone; Eduardo Tolosa; Niall Quinn; David B Goldstein; Nicholas W Wood; Paolo Barrone
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422
  5 in total
  11 in total

1.  Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer's disease.

Authors:  Maja Mustapic; Paola Presecki; Nela Pivac; Ninoslav Mimica; Patrick R Hof; Goran Simic; Vera Folnegovic-Smalc; Dorotea Muck-Seler
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-02-13       Impact factor: 5.067

Review 2.  Interleukin-1A -889C/T polymorphism and risk of Alzheimer's disease: a meta-analysis based on 32 case-control studies.

Authors:  Xue Qin; Qiliu Peng; Zhiyu Zeng; Zhiping Chen; Liwen Lin; Yan Deng; Xiamei Huang; Juanjuan Xu; Huiling Wu; Shan Huang; Shan Li; Jinmin Zhao
Journal:  J Neurol       Date:  2012-01-11       Impact factor: 4.849

3.  Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice.

Authors:  Thea Hammerschmidt; Markus P Kummer; Dick Terwel; Ana Martinez; Ali Gorji; Hans-Christian Pape; Karen S Rommelfanger; Jason P Schroeder; Monika Stoll; Joachim Schultze; David Weinshenker; Michael T Heneka
Journal:  Biol Psychiatry       Date:  2012-08-09       Impact factor: 13.382

4.  Confronting complexity in late-onset Alzheimer disease: application of two-stage analysis approach addressing heterogeneity and epistasis.

Authors:  Tricia A Thornton-Wells; Jason H Moore; Eden R Martin; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Genet Epidemiol       Date:  2008-04       Impact factor: 2.135

5.  The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project.

Authors:  Onofre Combarros; Donald R Warden; Naomi Hammond; Mario Cortina-Borja; Olivia Belbin; Michael G Lehmann; Gordon K Wilcock; Kristelle Brown; Patrick G Kehoe; Rachel Barber; Eliecer Coto; Victoria Alvarez; Panos Deloukas; Rhian Gwilliam; Reinhard Heun; Heike Kölsch; Ignacio Mateo; Abderrahim Oulhaj; Alejandro Arias-Vásquez; Maaike Schuur; Yurii S Aulchenko; M Arfan Ikram; Monique M Breteler; Cornelia M van Duijn; Kevin Morgan; A David Smith; Donald J Lehmann
Journal:  BMC Med Genet       Date:  2010-11-11       Impact factor: 2.103

6.  IL-6-174 G/C and -572 C/G polymorphisms and risk of Alzheimer's disease.

Authors:  Hui-Ping Qi; Zheng-Yi Qu; Shu-Rong Duan; Shu-Qin Wei; Shi-Rong Wen; Sheng Bi
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

Review 7.  Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases.

Authors:  Giuseppe Di Giovanni; Dubravka Svob Strac; Montse Sole; Mercedes Unzeta; Keith F Tipton; Dorotea Mück-Šeler; Irene Bolea; Laura Della Corte; Matea Nikolac Perkovic; Nela Pivac; Ilse J Smolders; Anna Stasiak; Wieslawa A Fogel; Philippe De Deurwaerdère
Journal:  Front Neurosci       Date:  2016-11-24       Impact factor: 4.677

8.  Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium.

Authors:  Timothy J Hohman; William S Bush; Lan Jiang; Kristin D Brown-Gentry; Eric S Torstenson; Scott M Dudek; Shubhabrata Mukherjee; Adam Naj; Brian W Kunkle; Marylyn D Ritchie; Eden R Martin; Gerard D Schellenberg; Richard Mayeux; Lindsay A Farrer; Margaret A Pericak-Vance; Jonathan L Haines; Tricia A Thornton-Wells
Journal:  Neurobiol Aging       Date:  2015-11-06       Impact factor: 4.673

Review 9.  Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease.

Authors:  Termpanit Chalermpalanupap; Becky Kinkead; William T Hu; Markus P Kummer; Thea Hammerschmidt; Michael T Heneka; David Weinshenker; Allan I Levey
Journal:  Alzheimers Res Ther       Date:  2013-04-29       Impact factor: 6.982

Review 10.  Chronic neuroprotective effects of low concentration lithium on SH-SY5Y cells: possible involvement of stress proteins and gene expression.

Authors:  Riadh Nciri; Ezzeddine Bourogaa; Samira Jbahi; Mohamed Salah Allagui; Abdelfattah Elfeki; Christian Vincent; Françoise Croute
Journal:  Neural Regen Res       Date:  2014-04-01       Impact factor: 5.135
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.